Validation of the method for determination of prekallikrein activator in Human Albumin
Prekallikrein activator (PKA) is regarded as one of the most important factors determining the safety of blood products such as albumin and intravenous immunoglobulin. PKA impurity at a high concentration may cause undesired side effects when administered to patients of blood products. According to...
Main Authors: | M. V. Tomilin, E. V. Filatova, M. M. Kuznetsova, V. V. Sudakova, N. V. Zubkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-02-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/83 |
Similar Items
-
Lisinopril-Induced Angioedema in a Patient with Plasma Prekallikrein Deficiency
by: Swapan K. Dasgupta, et al.
Published: (2020-01-01) -
STUDY CHROMATICITY CHARACTERISTICS OF WATER USING THE COMPUTER COLORIMETRY
by: V. M. Bolotov, et al.
Published: (2013-10-01) -
Полимерные наносистемы для транспорта противоопухолевых и противотуберкулезных препаратов
by: M. Burkeev, et al.
Published: (2013-05-01) -
Ivermectin pharmacokinetics in horses organism after the application of Equiverm antiparasitic paste
by: M. B. Musaev, et al.
Published: (2019-10-01) -
Comparison of the State Pharmacopoeia, XIII edition and the European Pharmacopoeia requirements for human plasma products
by: A. V. Karyakin, et al.
Published: (2018-02-01)